Intravenous (IV) Solutions Market Report

Global and Region Intravenous (IV) Solutions Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：219
  • REPORT CODE：GMM887942
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Intravenous (IV) Solutions market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Intravenous (IV) Solutionsmarket, defines the market attractiveness level of Intravenous (IV) Solutions market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Intravenous (IV) Solutions industry, describes the types of Intravenous (IV) Solutions market, the applications of major players and the market size, and deeply analyzes the current situation of the global Intravenous (IV) Solutions market and the development prospects and opportunities of Intravenous (IV) Solutions industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Intravenous (IV) Solutions market in Chapter 13.

    By Player:

    • B Braun Melsungen AG (Germany)

    • ICU Medical Inc (US)

    • Terumo Medical Corporation (Tokyo)

    • Baxter (US)

    • Fresenius Kabi AG (Germany)

    • Grifols SA (Spain)

    • Amanta Healthcare (India)

    By Type:

    • Peripheral Parenteral Nutrition

    • Total Parenteral Nutrition

    By End-User:

    • Hospital & Clinics

    • Ambulatory

    • Home Care

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Intravenous (IV) Solutions Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Intravenous (IV) Solutions Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Intravenous (IV) Solutions Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Intravenous (IV) Solutions Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Intravenous (IV) Solutions Market Analysis and Outlook to 2022

    • 7.1 Global Intravenous (IV) Solutions Consumption (2017-2022)

    • 7.2 United States Intravenous (IV) Solutions Consumption (2017-2022)

    • 7.3 Europe Intravenous (IV) Solutions Consumption (2017-2022)

    • 7.4 China Intravenous (IV) Solutions Consumption (2017-2022)

    • 7.5 Japan Intravenous (IV) Solutions Consumption (2017-2022)

    • 7.6 India Intravenous (IV) Solutions Consumption (2017-2022)

    • 7.7 South Korea Intravenous (IV) Solutions Consumption (2017-2022)

    8 Region and Country-wise Intravenous (IV) Solutions Market Analysis and Outlook to 2028

    • 8.1 Global Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 8.2 United States Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 8.3 Europe Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 8.4 China Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 8.5 Japan Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 8.6 India Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 8.7 South Korea Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    9 Global Intravenous (IV) Solutions Market Outlook by Types and Applications to 2022

    • 9.1 Global Intravenous (IV) Solutions Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Peripheral Parenteral Nutrition Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Total Parenteral Nutrition Consumption and Growth Rate (2017-2022)

    • 9.2 Global Intravenous (IV) Solutions Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital & Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)

    10 Global Intravenous (IV) Solutions Market Outlook by Types and Applications to 2028

    • 10.1 Global Intravenous (IV) Solutions Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Peripheral Parenteral Nutrition Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Total Parenteral Nutrition Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Intravenous (IV) Solutions Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital & Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)

    11 Global Intravenous (IV) Solutions Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Intravenous (IV) Solutions Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Intravenous (IV) Solutions Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Intravenous (IV) Solutions Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Intravenous (IV) Solutions Market Competitive Analysis

    • 14.1 B Braun Melsungen AG (Germany)

      • 14.1.1 B Braun Melsungen AG (Germany) Company Details

      • 14.1.2 B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product and Service

    • 14.2 ICU Medical Inc (US)

      • 14.2.1 ICU Medical Inc (US) Company Details

      • 14.2.2 ICU Medical Inc (US) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 ICU Medical Inc (US) Intravenous (IV) Solutions Product and Service

    • 14.3 Terumo Medical Corporation (Tokyo)

      • 14.3.1 Terumo Medical Corporation (Tokyo) Company Details

      • 14.3.2 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product and Service

    • 14.4 Baxter (US)

      • 14.4.1 Baxter (US) Company Details

      • 14.4.2 Baxter (US) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Baxter (US) Intravenous (IV) Solutions Product and Service

    • 14.5 Fresenius Kabi AG (Germany)

      • 14.5.1 Fresenius Kabi AG (Germany) Company Details

      • 14.5.2 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product and Service

    • 14.6 Grifols SA (Spain)

      • 14.6.1 Grifols SA (Spain) Company Details

      • 14.6.2 Grifols SA (Spain) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Grifols SA (Spain) Intravenous (IV) Solutions Product and Service

    • 14.7 Amanta Healthcare (India)

      • 14.7.1 Amanta Healthcare (India) Company Details

      • 14.7.2 Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Amanta Healthcare (India) Intravenous (IV) Solutions Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Intravenous (IV) Solutions

    • Figure Intravenous (IV) Solutions Picture

    • Table Global Intravenous (IV) Solutions Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Intravenous (IV) Solutions Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Intravenous (IV) Solutions Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Intravenous (IV) Solutions Consumption by Country (2017-2022)

    • Figure United States Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Table Europe Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure China Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Japan Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure India Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure South Korea Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Global Intravenous (IV) Solutions Consumption Forecast by Country (2022-2028)

    • Figure United States Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Peripheral Parenteral Nutrition Consumption and Growth Rate (2017-2022)

    • Figure Global Total Parenteral Nutrition Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital & Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Consumption and Growth Rate (2017-2022)

    • Figure Global Home Care Consumption and Growth Rate (2017-2022)

    • Figure Global Peripheral Parenteral Nutrition Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Total Parenteral Nutrition Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital & Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Intravenous (IV) Solutions Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Intravenous (IV) Solutions Export by Region (Top 5 Countries) (2017-2028)

    • Table B Braun Melsungen AG (Germany) (Foundation Year, Company Profile and etc.)

    • Table B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product and Service

    • Table ICU Medical Inc (US) (Foundation Year, Company Profile and etc.)

    • Table ICU Medical Inc (US) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table ICU Medical Inc (US) Intravenous (IV) Solutions Product and Service

    • Table Terumo Medical Corporation (Tokyo) (Foundation Year, Company Profile and etc.)

    • Table Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product and Service

    • Table Baxter (US) (Foundation Year, Company Profile and etc.)

    • Table Baxter (US) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter (US) Intravenous (IV) Solutions Product and Service

    • Table Fresenius Kabi AG (Germany) (Foundation Year, Company Profile and etc.)

    • Table Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product and Service

    • Table Grifols SA (Spain) (Foundation Year, Company Profile and etc.)

    • Table Grifols SA (Spain) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols SA (Spain) Intravenous (IV) Solutions Product and Service

    • Table Amanta Healthcare (India) (Foundation Year, Company Profile and etc.)

    • Table Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amanta Healthcare (India) Intravenous (IV) Solutions Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US